JP2010512361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512361A5 JP2010512361A5 JP2009540659A JP2009540659A JP2010512361A5 JP 2010512361 A5 JP2010512361 A5 JP 2010512361A5 JP 2009540659 A JP2009540659 A JP 2009540659A JP 2009540659 A JP2009540659 A JP 2009540659A JP 2010512361 A5 JP2010512361 A5 JP 2010512361A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- autoimmune
- syndrome
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001363 autoimmune Effects 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 208000023275 Autoimmune disease Diseases 0.000 claims 5
- 208000011580 syndromic disease Diseases 0.000 claims 5
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims 4
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 239000010836 blood and blood product Substances 0.000 claims 2
- 229940125691 blood product Drugs 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 208000026872 Addison Disease Diseases 0.000 claims 1
- 208000032671 Allergic granulomatous angiitis Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000003343 Antiphospholipid Syndrome Diseases 0.000 claims 1
- 208000032467 Aplastic anaemia Diseases 0.000 claims 1
- 208000002017 Autoimmune Hypophysitis Diseases 0.000 claims 1
- 206010003827 Autoimmune hepatitis Diseases 0.000 claims 1
- 206010064539 Autoimmune myocarditis Diseases 0.000 claims 1
- 208000023328 Basedow disease Diseases 0.000 claims 1
- 208000009137 Behcet syndrome Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- 201000002829 CREST Syndrome Diseases 0.000 claims 1
- 101100245267 Caenorhabditis elegans pas-1 gene Proteins 0.000 claims 1
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 claims 1
- 208000006344 Churg-Strauss Syndrome Diseases 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 claims 1
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000019707 Cryoglobulinemic vasculitis Diseases 0.000 claims 1
- 206010011878 Deafness Diseases 0.000 claims 1
- 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 claims 1
- 208000007465 Giant cell arteritis Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 102100035716 Glycophorin-A Human genes 0.000 claims 1
- 102100036430 Glycophorin-B Human genes 0.000 claims 1
- 208000024869 Goodpasture syndrome Diseases 0.000 claims 1
- 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 1
- 101001074244 Homo sapiens Glycophorin-A Proteins 0.000 claims 1
- 101001071776 Homo sapiens Glycophorin-B Proteins 0.000 claims 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000011200 Kawasaki disease Diseases 0.000 claims 1
- 206010064281 Malignant atrophic papulosis Diseases 0.000 claims 1
- 208000027530 Meniere disease Diseases 0.000 claims 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 1
- 208000003250 Mixed connective tissue disease Diseases 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 206010034277 Pemphigoid Diseases 0.000 claims 1
- 201000011152 Pemphigus Diseases 0.000 claims 1
- 241000721454 Pemphigus Species 0.000 claims 1
- 208000031845 Pernicious anaemia Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 208000003782 Raynaud disease Diseases 0.000 claims 1
- 208000012322 Raynaud phenomenon Diseases 0.000 claims 1
- 208000033464 Reiter syndrome Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 206010042742 Sympathetic ophthalmia Diseases 0.000 claims 1
- 208000001106 Takayasu Arteritis Diseases 0.000 claims 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims 1
- 206010043784 Thyroiditis subacute Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 208000013633 acquired hemophilia Diseases 0.000 claims 1
- 208000004631 alopecia areata Diseases 0.000 claims 1
- 206010003230 arteritis Diseases 0.000 claims 1
- 201000005000 autoimmune gastritis Diseases 0.000 claims 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 1
- 208000020176 autoimmune hypoparathyroidism Diseases 0.000 claims 1
- 208000027625 autoimmune inner ear disease Diseases 0.000 claims 1
- 201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 claims 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 1
- 201000003278 cryoglobulinemia Diseases 0.000 claims 1
- 201000001981 dermatomyositis Diseases 0.000 claims 1
- 230000002124 endocrine Effects 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 230000010370 hearing loss Effects 0.000 claims 1
- 231100000888 hearing loss Toxicity 0.000 claims 1
- 208000016354 hearing loss disease Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 201000005737 orchitis Diseases 0.000 claims 1
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 1
- 208000005987 polymyositis Diseases 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 208000011610 primary hypophysitis Diseases 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 208000002574 reactive arthritis Diseases 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 201000007497 subacute thyroiditis Diseases 0.000 claims 1
- 206010043207 temporal arteritis Diseases 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0624874.4A GB0624874D0 (en) | 2006-12-13 | 2006-12-13 | Treatment |
| GB0624874.4 | 2006-12-13 | ||
| PCT/EP2007/010904 WO2008071418A2 (en) | 2006-12-13 | 2007-12-12 | Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512361A JP2010512361A (ja) | 2010-04-22 |
| JP2010512361A5 true JP2010512361A5 (enExample) | 2011-02-10 |
| JP5414532B2 JP5414532B2 (ja) | 2014-02-12 |
Family
ID=37712062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009540659A Expired - Fee Related JP5414532B2 (ja) | 2006-12-13 | 2007-12-12 | 免疫グロブリンＧ媒介性疾患を治療するためのエンドグリコシダーゼＥｎｄｏＳの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8889128B2 (enExample) |
| EP (1) | EP2099477B1 (enExample) |
| JP (1) | JP5414532B2 (enExample) |
| CN (1) | CN101605557B (enExample) |
| AU (1) | AU2007331736B2 (enExample) |
| CA (1) | CA2671736C (enExample) |
| ES (1) | ES2426352T3 (enExample) |
| GB (1) | GB0624874D0 (enExample) |
| WO (1) | WO2008071418A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8691544B2 (en) * | 2007-05-04 | 2014-04-08 | Glycorex Transplantation Ab | Material for separation of a biomolecule |
| GB0821100D0 (en) * | 2008-11-18 | 2008-12-24 | Hansa Medical Ab | Antibodies |
| EP2498812A4 (en) * | 2009-11-13 | 2013-05-22 | Bengt Guss | IMMUNIZATION COMPOSITION FOR REDUCING STREPTOCOCCAL INFECTIONS |
| EP3135684B1 (en) | 2010-05-26 | 2023-06-28 | Intervacc AB | Vaccine against streptococcal infections based on recombinant fusion proteins |
| GB201103780D0 (en) | 2011-03-04 | 2011-04-20 | Hansa Medical Ab | Treatment for ige-mediated disease |
| GB201115841D0 (en) * | 2011-09-13 | 2011-10-26 | Genovis Ab | Protein and method |
| GB201201314D0 (en) * | 2012-01-26 | 2012-03-07 | Isis Innovation | Composition |
| BR112014019825B1 (pt) * | 2012-02-10 | 2021-08-24 | University Of Maryland, Baltimore | Glicoengenharia quimioenzimática de anticorpos e fragmentos fc dos mesmos |
| TWI682033B (zh) | 2014-03-17 | 2020-01-11 | 泉盛生物科技股份有限公司 | 製造具有經修飾的糖苷化作用之重組糖蛋白之方法 |
| GB201413240D0 (en) * | 2014-07-25 | 2014-09-10 | Hansa Medical Ab | Method |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| ES2986557T3 (es) | 2017-05-26 | 2024-11-11 | Genovis Ab | Enzimas para el análisis de glucanos |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| CN108623696B (zh) * | 2018-04-20 | 2021-05-28 | 江南大学 | 一种利用纤维素固定化CBD-EndoS融合酶的方法 |
| US20200165608A1 (en) * | 2018-11-23 | 2020-05-28 | Florida State University Research Foundation, Inc. | Inhibition of vascular endothelial cell-mediated phagocytic processes for treatment of demyelinating conditions |
| GB202003129D0 (en) * | 2020-03-04 | 2020-04-15 | Hansa Biopharma AB | Conditioning regimen for transplant of stem cells |
| GB202007434D0 (en) * | 2020-05-19 | 2020-07-01 | Hansa Biopharma AB | Methods |
| US20230374542A1 (en) | 2020-10-07 | 2023-11-23 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21) |
| CN113009130B (zh) * | 2021-02-10 | 2022-08-23 | 中国医学科学院北京协和医院 | 一种用于诊断原发性干燥综合征的生物标志物及其用途 |
| WO2022221529A1 (en) | 2021-04-16 | 2022-10-20 | Asklepios Biopharmaceutical, Inc. | Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response |
| EP4302770A1 (en) * | 2022-07-08 | 2024-01-10 | Hansa Biopharma AB | Regimen for enzymatic desensitisation |
| WO2025014862A1 (en) * | 2023-07-07 | 2025-01-16 | Emory University | Recombinant glycosidases, pharmaceutical compositions, and uses in managing autoimmune or inflammatory conditions |
| CN119709701A (zh) * | 2023-09-28 | 2025-03-28 | 上海糖岭生物医药有限责任公司 | 糖苷内切酶s2突变体、其制备方法及其在抗体糖基化改造中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130228D0 (en) | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| DK1601770T3 (da) * | 2003-03-04 | 2009-11-02 | Intercell Ag | Streptococcus pyogenes antigener |
| AU2005294275B2 (en) * | 2004-10-08 | 2012-09-13 | Glaxosmithkline Biologicals S.A. | Immunogenic and therapeutic compositions for Streptococcus pyogenes |
-
2006
- 2006-12-13 GB GBGB0624874.4A patent/GB0624874D0/en not_active Ceased
-
2007
- 2007-12-12 WO PCT/EP2007/010904 patent/WO2008071418A2/en not_active Ceased
- 2007-12-12 JP JP2009540659A patent/JP5414532B2/ja not_active Expired - Fee Related
- 2007-12-12 CN CN2007800512493A patent/CN101605557B/zh not_active Expired - Fee Related
- 2007-12-12 US US12/518,855 patent/US8889128B2/en active Active
- 2007-12-12 CA CA2671736A patent/CA2671736C/en active Active
- 2007-12-12 EP EP07856650.2A patent/EP2099477B1/en active Active
- 2007-12-12 AU AU2007331736A patent/AU2007331736B2/en not_active Ceased
- 2007-12-12 ES ES07856650T patent/ES2426352T3/es active Active